We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Full Face Transplants Transform Victims Lives

By HospiMedica International staff writers
Posted on 25 Jan 2012
A new study describing the largest series worldwide of full-face transplantation (FFT) details patient preparation, design and execution of the operation, as well as a unique immune-suppression protocol that allows for a low long-term maintenance drug regimen. More...


A surgical team at Brigham and Women's Hospital (BWH; Boston, MA, USA) documented FFT process, from screening candidates to the transplant procedure itself and the follow up management of the recipients. The process includes evaluation by a team of physicians that determine whether the patient is prepared physically and mentally for the procedure through numerous clinical and psychological evaluations. Once a candidate is approved by the face transplant team, the physicians work closely with the New England Organ Bank (NEOB) to identify the criteria for suitable donors and the process for obtaining consent for the transplantation.

Next, the researchers outlined the details of the surgeries, with a focus on the multidisciplinary collaborative efforts of an entire team of clinicians. Surgeons and staff coordinate their tasks while preparing the recipient, simultaneously retrieving the donor tissue within a limited time frame. The researchers described the similarities and difference between each procedure, noting the various differences that occurred in the one FFT recipient who also concurrently received a bilateral hand transplant.

Lastly, the researchers explained the care of the recipient posttransplant. Following the surgery, physicians monitor and adjust immunosuppressants while methodically screening for any signs of organ rejection. The researchers also discussed the occurrence of single rejection episodes in two patients, as well as describing how the transplanted tissue transformed and adapted to match the features of the recipient in each case. They also shared details of the early functional outcomes and discussed FFT as a viable option in the treatment of severe facial deformities and injuries. The study was published ahead of print on December 28, 2011, in the New England Journal of Medicine (NEJM).

“Unlike conventional reconstruction, facial transplantation seeks to transform severely deformed features to a near-normal appearance and function that conventional reconstructive plastic surgical techniques cannot match,” said lead author Bohdan Pomahac, MD, director of the plastic surgery transplantation program at BWH and lead surgeon in all three FFT procedures. “It truly is a life-giving procedure for these patients.”

Related Links:

Brigham and Women's Hospital




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.